507 related articles for article (PubMed ID: 32751080)
21. GSTZ1-1 Deficiency Activates NRF2/IGF1R Axis in HCC via Accumulation of Oncometabolite Succinylacetone.
Yang F; Li J; Deng H; Wang Y; Lei C; Wang Q; Xiang J; Liang L; Xia J; Pan X; Li X; Long Q; Chang L; Xu P; Huang A; Wang K; Tang N
EMBO J; 2019 Aug; 38(15):e101964. PubMed ID: 31267557
[TBL] [Abstract][Full Text] [Related]
22. SLC27A5 deficiency activates NRF2/TXNRD1 pathway by increased lipid peroxidation in HCC.
Gao Q; Zhang G; Zheng Y; Yang Y; Chen C; Xia J; Liang L; Lei C; Hu Y; Cai X; Zhang W; Tang H; Chen Y; Huang A; Wang K; Tang N
Cell Death Differ; 2020 Mar; 27(3):1086-1104. PubMed ID: 31367013
[TBL] [Abstract][Full Text] [Related]
23. The discovery and characterization of K-563, a novel inhibitor of the Keap1/Nrf2 pathway produced by Streptomyces sp.
Hori R; Yamaguchi K; Sato H; Watanabe M; Tsutsumi K; Iwamoto S; Abe M; Onodera H; Nakamura S; Nakai R
Cancer Med; 2019 Mar; 8(3):1157-1168. PubMed ID: 30735010
[TBL] [Abstract][Full Text] [Related]
24. Novel diterpenoid-type activators of the Keap1/Nrf2/ARE signaling pathway and their regulation of redox homeostasis.
Li AL; Shen T; Wang T; Zhou MX; Wang B; Song JT; Zhang PL; Wang XL; Ren DM; Lou HX; Wang XN
Free Radic Biol Med; 2019 Sep; 141():21-33. PubMed ID: 31167117
[TBL] [Abstract][Full Text] [Related]
25. Activation of AKT pathway by Nrf2/PDGFA feedback loop contributes to HCC progression.
Liu D; Zhang Y; Wei Y; Liu G; Liu Y; Gao Q; Zou L; Zeng W; Zhang N
Oncotarget; 2016 Oct; 7(40):65389-65402. PubMed ID: 27588483
[TBL] [Abstract][Full Text] [Related]
26. Different Inhibition of Nrf2 by Two Keap1 Isoforms α and β to Shape Malignant Behaviour of Human Hepatocellular Carcinoma.
Chen F; Xiao M; Feng J; Wufur R; Liu K; Hu S; Zhang Y
Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142252
[TBL] [Abstract][Full Text] [Related]
27. Stress-sensing mechanisms and the physiological roles of the Keap1-Nrf2 system during cellular stress.
Suzuki T; Yamamoto M
J Biol Chem; 2017 Oct; 292(41):16817-16824. PubMed ID: 28842501
[TBL] [Abstract][Full Text] [Related]
28. LKB1 and KEAP1/NRF2 Pathways Cooperatively Promote Metabolic Reprogramming with Enhanced Glutamine Dependence in
Galan-Cobo A; Sitthideatphaiboon P; Qu X; Poteete A; Pisegna MA; Tong P; Chen PH; Boroughs LK; Rodriguez MLM; Zhang W; Parlati F; Wang J; Gandhi V; Skoulidis F; DeBerardinis RJ; Minna JD; Heymach JV
Cancer Res; 2019 Jul; 79(13):3251-3267. PubMed ID: 31040157
[TBL] [Abstract][Full Text] [Related]
29.
Nabeshima T; Hamada S; Taguchi K; Tanaka Y; Matsumoto R; Yamamoto M; Masamune A
Am J Physiol Gastrointest Liver Physiol; 2020 Mar; 318(3):G419-G427. PubMed ID: 31961719
[TBL] [Abstract][Full Text] [Related]
30. The oncoprotein HBXIP competitively binds KEAP1 to activate NRF2 and enhance breast cancer cell growth and metastasis.
Zhou XL; Zhu CY; Wu ZG; Guo X; Zou W
Oncogene; 2019 May; 38(21):4028-4046. PubMed ID: 30692632
[TBL] [Abstract][Full Text] [Related]
31. Protection against oxidative stress mediated by the Nrf2/Keap1 axis is impaired in Primary Biliary Cholangitis.
Wasik U; Milkiewicz M; Kempinska-Podhorodecka A; Milkiewicz P
Sci Rep; 2017 Mar; 7():44769. PubMed ID: 28333129
[TBL] [Abstract][Full Text] [Related]
32. The Dual Roles of NRF2 in Cancer.
Menegon S; Columbano A; Giordano S
Trends Mol Med; 2016 Jul; 22(7):578-593. PubMed ID: 27263465
[TBL] [Abstract][Full Text] [Related]
33. S-1-propenylmercaptocysteine protects murine hepatocytes against oxidative stress via persulfidation of Keap1 and activation of Nrf2.
Tocmo R; Parkin K
Free Radic Biol Med; 2019 Nov; 143():164-175. PubMed ID: 31349040
[TBL] [Abstract][Full Text] [Related]
34. Ptgr1 expression is regulated by NRF2 in rat hepatocarcinogenesis and promotes cell proliferation and resistance to oxidative stress.
Sánchez-Rodríguez R; Torres-Mena JE; Quintanar-Jurado V; Chagoya-Hazas V; Rojas Del Castillo E; Del Pozo Yauner L; Villa-Treviño S; Pérez-Carreón JI
Free Radic Biol Med; 2017 Jan; 102():87-99. PubMed ID: 27867096
[TBL] [Abstract][Full Text] [Related]
35. Transcription factor Nrf2/MafK regulates rat placental glutathione S-transferase gene during hepatocarcinogenesis.
Ikeda H; Nishi S; Sakai M
Biochem J; 2004 Jun; 380(Pt 2):515-21. PubMed ID: 14960151
[TBL] [Abstract][Full Text] [Related]
36. Simultaneous K-ras activation and Keap1 deletion cause atrophy of pancreatic parenchyma.
Hamada S; Shimosegawa T; Taguchi K; Nabeshima T; Yamamoto M; Masamune A
Am J Physiol Gastrointest Liver Physiol; 2018 Jan; 314(1):G65-G74. PubMed ID: 28971839
[TBL] [Abstract][Full Text] [Related]
37. Molecular mechanisms and systemic targeting of NRF2 dysregulation in cancer.
Kang JS; Nam LB; Yoo OK; Keum YS
Biochem Pharmacol; 2020 Jul; 177():114002. PubMed ID: 32360363
[TBL] [Abstract][Full Text] [Related]
38. NRF2/SHH signaling cascade promotes tumor-initiating cell lineage and drug resistance in hepatocellular carcinoma.
Leung HW; Lau EYT; Leung CON; Lei MML; Mok EHK; Ma VWS; Cho WCS; Ng IOL; Yun JP; Cai SH; Yu HJ; Ma S; Lee TKW
Cancer Lett; 2020 Apr; 476():48-56. PubMed ID: 32061952
[TBL] [Abstract][Full Text] [Related]
39. Nrf2-Keap1 signaling in oxidative and reductive stress.
Bellezza I; Giambanco I; Minelli A; Donato R
Biochim Biophys Acta Mol Cell Res; 2018 May; 1865(5):721-733. PubMed ID: 29499228
[TBL] [Abstract][Full Text] [Related]
40. AICAR induces Nrf2 activation by an AMPK-independent mechanism in hepatocarcinoma cells.
Sid B; Glorieux C; Valenzuela M; Rommelaere G; Najimi M; Dejeans N; Renard P; Verrax J; Calderon PB
Biochem Pharmacol; 2014 Sep; 91(2):168-80. PubMed ID: 25058527
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
